Based on the results of network pharmacology screening, we hypothesized that agrimol B could protect against CDDP-induced AKI by targeting the protein Sirt1, and further investigations were conducted in animal experimental models to verify this hypothesis. Here, SIRT1 is linked to acute kidney injury.